OpenAI AI Agent Swarm Behind Hugging Face Hack 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Toyota Global Sales Fall as China Demand Slumps 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Tesla Raises Cybertruck Prices by $5,000 in US 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Add as a preferred source on Google
Raipur, April 19, 2018 -- Report Sellers has added a new market research report “Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022” to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.
Electrophysiology is the study of electrical system of the heart in order to determine best treatment option for cardiac arrhythmia. Some of the most common indications where EP is used are Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNR), Wolff-Parkinson-White Syndrome (WPW), among others. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia characterised by loss of the normal electrical rhythm of the heart. There are two main types of atrial fibrillation-Paroxysmal atrial fibrillation and Persistent or permanent atrial fibrillation. Based on unique needs of patient, cardiologist discusses symptoms with the patient and determine proper treatment based on unique needs of each patient.
Growth of global electrophysiology/atrial fibrillation ablation market is primarily attributed to factors such as higher prevalence of atrial fibrillation, rise in number of hypertension patients, increasing incidence of valvular heart diseases, growing geriatric population and increasing demand for minimally invasive procedure. However, the market faces challenges due to stringent regulatory approval, reimbursement issues, dearth of skilled professionals and treatment skewed towards pharmaceutical intervention. The market is characterized by leading trends such as FIRM-guided ablation for atrial fibrillation, rise in number of mergers and acquisitions and advent of New Oral Anticoagulants (NOACS).
Browse through the complete description and in-depth TOC on “Global Electrophysiology/Atrial Fibrillation Ablation Market”
Major industry players operating in the global electrophysiology/atrial fibrillation ablation market include Medtronic Plc, Biosense Webster, Inc., Abbott Laboratories, Boston Scientific Corporation, among others.
Related Reports
https://www.reportsellers.com/market-research-report/Helicobacter-Pylori-Testing-Market-237
https://www.reportsellers.com/market-research-report/Acinetobacter-Infections-Treatment-Market-9234
https://www.reportsellers.com/market-research-report/Vitro-Diagnostics-IVD-Market-288
We have a large number of reports in other Healthcare Industry which can be accessed in the following link:
https://www.reportsellers.com/category/healthcare-market-research-report
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.
Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
Report Sellers Email: [email protected] Direct: +1-214-396-2385
